Zhaohui Wei

Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival

Ying Cheng, B. Ye, Hui-min Tao, 2020, Cancer science.

Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial.

Ying Cheng, C. Bai, Yi-long Wu, 2013, The Lancet. Oncology.

Icotinib versus gefi tinib in previously treated advanced non-small-cell lung cancer ( ICOGEN ) : a randomised , double-blind phase 3 non-inferiority trial

C. Bai, Yuankai Shi, S. Qin, 2013 .